Columbia Labs (CBRX) Posts Narrower than Expected Q1 Loss

Columbia Laboratories Inc. (NASDAQ: CBRX) reported Q1 EPS of ($0.01), $0.05 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $12.5 million versus the consensus estimate of $4.76 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
• Acuity Brands (AYI) Tops Q4 EPS by 11c
• Jefferies Financial stock slips 3% as Fixed Income, Asset Management revenues fall